About Seismic

A Firm Built by FQHC Operators

Seismic Health Strategies is a national healthcare consulting firm built by people who have held the C-suite seats, run the P&L, and owned the results — not advised from the outside. We combine deep 340B pharmacy expertise, operations and strategy leadership, compliance and audit-readiness, and an AI-enabled intelligence platform to help community health centers grow, stay compliant, and control their own sustainability.

Leadership

The firm is founded and led by J. Wyndy Webb, PharmD, MBA, HCEP, PMP, 340B ACE — Founder, CEO, and Lead Consultant. Wyndy has spent more than 25 years in Leadership of Federally Qualified Health Centers — as Chief Strategy Officer, Chief Operating Officer, and Chief Pharmacy Officer, frequently holding COO and CPO at once. She has provided expert testimony before the Maryland State Legislature in support of HB1056 and SB986, contributing to legislation prohibiting discriminatory 340B distribution practices.

The Team

Wyndy leads a team of seasoned FQHC consultants and specialists whose combined expertise spans every service Seismic offers — 340B, pharmacy operations, fractional C-suite leadership, revenue cycle, HRSA and multi-agency compliance, AI governance, and operational intelligence. Several have themselves held multiple C-suite positions inside community health centers.

Under the firm's leadership, client health centers have grown 340B revenue from 6% to 37% of total organizational revenue, generated more than $100M in cumulative pharmacy revenue, cut call abandonment from 53% to 5%, and secured a first successful HRSA site visit after two consecutive failures. Beyond FQHCs, Seismic serves correctional healthcare systems and behavioral health organizations facing the same pressures.

Results That Fund Patient Care

Growth From Optimization, Not Expansion

Every figure below was achieved without increasing patient volume or adding providers.

6% → 37%
Nine-site Maryland FQHC · entity-owned pharmacy designed and implemented
  • $34.8M cumulative pharmacy revenue over three years; $50M at 4.5 years
  • Annual 340B revenue $2.1M (2021) to $12M+ (2024)
  • $2M recovered via 340B look-back
  • Rx volume up 42%; capture rate 91%
>$13M / yr
Five-site New York FQHC · no entity-owned pharmacy
  • Contract pharmacy revenue up 125% year over year
  • Pharmacy contribution 26% (2023) → 31% (2025) → 36% (2026)
  • Net pharmacy income $4.1M, restoring pre-carve-out performance
  • Network expanded 15 locations; 3% COGS reduction
53% → 5%
Operational turnaround · Patient Access Center redesign
  • Scheduled appointments up 29%; +$700K annual revenue
  • Credentialing turnaround cut 40%; +$1M revenue
  • A/R reduced 70%; collections up 30%
  • First successful HRSA OSV after two failures — $20M+ secured
Let's Talk

Let's Find What Your Program Is Missing

Most health centers we assess discover revenue they did not know they were losing. The first conversation costs nothing and usually takes thirty minutes.